Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Severance hospital, Seoul, South Korea
Contact: Study coordinator (Chan Woo Wee, MD, PhD) · wcw0108@yuhs.ac · +82-2-2228-8121

Study leads

Chan Woo Wee, MD, PhD
Study Chair
Severance Hospital
In Ah Kim, MD, PhD
Study Chair
Seoul National University Bundang Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Glioblastoma (GBM) · Newly Diagnosed Glioblastoma · GBM

Abroad (travel likely)RecruitingPHASE2

Springdale, United States · Los Angeles, United States

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Glioblastoma Multiforme (GBM) · Glioblastoma · Glioma of Brain

Abroad (travel likely)RecruitingPHASE1, PHASE2

New York, United States

5G-PEARL: Paxalisib in Malignant Brain Tumours

Malignant Primary Gliomas · Glioblastoma Multiforme (GBM)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sutton, United Kingdom

Antisecretory Factor Glioblastoma Phase 2

Glioblastoma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Lund, Sweden